In the wake of reports of violation of ethical guidelines and exploitation during the “clinical trials” of HPV (human papilloma virus) vaccine, meant to prevent cervical cancer among women, the Centre on Wednesday advised the State governments to suspend the vaccine programme until the issue is settled. Director-General of the Indian Council of Medical Research V.M. Katoch told The Hindu that he had asked the Health Ministry, the State governments and...
More »SEARCH RESULT
Swaminathan’s concerns can’t be addressed: nutrition body chief by Jacob P Koshy
Sesikaran says Bt crop’s long-term effect on health can be studied only if it’s approved for commercial production Concerns raised by agriculture scientist M.S. Swaminathan, cited by the government as among the reasons to put a halt to the release of Bt brinjal, will be impossible to address, according to the head of a state-run laboratory. Swaminathan, 84, credited with the success of the Green Revolution of the 1960s that made India...
More »Biotechnology regulation
The controversy around Bt brinjal has served at least one good purpose. The government has fast-tracked the process of setting up a biotechnology regulator. A regulatory authority is to be set up under an Act of Parliament. A longstanding proposal that has been gathering dust in the Department of Biotechnology has seen the light of day. The Union Cabinet is expected to consider this proposal and bring it to Parliament....
More »Post-Bt brinjal, GM regulator is top priority
It is a step which is expected to reduce the room for political and technical whims and biases, bring in transparency and satisfy safety concerns about biotech products the country needs but is chary of embracing. The government has fasttracked a long-pending Bill to set up the Biotechnology Regulatory Authority. The Bill, revised and discussed by a committee of secretaries on Thursday, if cleared, would overhaul the current flawed regulatory...
More »Health ministry to import 1.5 million doses of H1N1 vaccine by Radhieka Pandeya
The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. “We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of...
More »